Answers are grounded in this paper and cite their sources.
Donor-screening practices remain heterogeneous across European human milk banks, despite increasing efforts to harmonise donor milk safety and processing standards through the IMAGINE-HMB initiative and the European Substances of Human Origin (SoHO) framework. Recommendations for screening aimed at reducing the risk of viral transmission through human milk often depend on the local epidemiological context, including population seroprevalence and the risk of mother to child infection with a given pathogen. CMV seroprevalence among women of reproductive age varies considerably across Europe, ranging from approximately 46% to 96%, with substantial differences between countries and populations. Given the high CMV seroprevalence among women of reproductive age in Poland (80%), the utility of CMV serology in donor screening warrants reconsideration, particularly when donor human milk is routinely pasteurised. The aim of this study was to assess the concordance between CMV serological status of human milk donors and the detection of CMV DNA in the donated human milk. Twenty lactating mothers willing to become human milk donors were recruited at the Regional Human Milk in Holy Family Hospital in Warsaw. As part of the mandatory screening procedure, donors underwent CMV IgG and IgM serological testing. Three milk samples from each donor (totalling 60 samples) were collected at monthly intervals following a 0-1-2 scheme from each donor and analysed using qualitative and quantitative PCR. Real-time PCR was used as the reference method to assess concordance Mean maternal age was 30.75 years, mean postpartum time was 3.06 months.0/20 donors had CMV IgM detected, while 9/20 had detectable CMV IgG. Among samples with detectable CMV DNA, median viral load decreased with progressing time. The IgM model showed 0% sensitivity, whereas qualitative PCR achieved 88.2% sensitivity. Qualitative PCR had a higher negative predictive value (95.1% vs 71.7%) and overall accuracy (90.0% vs 71.7%). IgM serology-based screening demonstrated limited concordance with CMV viral DNA detection in human milk, while qualitative PCR-based classification more closely reflected viral DNA presence. We recommend that regional milk banks align internal policies with EMBA guidance to optimise allocation of resources and support reconsideration of CMV serology screening for human milk donors to meet future European Substances of Human origin requirements.
No takes yet. Share an insight, caveat, or question.
Santhakumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: